Munich-based firm Ortivity raises substantial funding for their physician-focused business model

In a strategic move to strengthen its position in the German orthopedic care market, Ortivity – the leading outpatient orthopedic care platform in the country – has secured a substantial investment from the Swiss private equity firm, Unigestion.

Founded in 2022 by Apheon and Dr. med. Reinhard Wichels, Ortivity operates under a unique physician-led partnership model that ensures an even distribution of ownership among doctors and capital providers. This model has been instrumental in Ortivity's growth, with over 100 locations across three regional clusters.

Apheon, which remains the lead investor, will continue to hold the majority stake following this investment. The financing round, led by Apheon, includes Unigestion acquiring a significant minority stake. The transaction, subject to regulatory approval, is expected to provide Ortivity with additional capital for growth and investment in top-notch patient care.

Dr. med. Michael Thorwarth, who has been appointed as Co-CEO of Ortivity, emphasized the goal of setting new benchmarks in treatment quality and patient-centered services. His appointment is expected to contribute to creating measurable benefits for Ortivity's patients.

Nils Lüssem, Partner at Apheon, and Sebastian Walter, Director at Apheon, commented that the partnership with Unigestion ensures they have the necessary capital to continue their growth and invest in top-notch patient care.

Ortivity offers a full range of orthopedic services, including diagnostics, surgery, and aftercare. The new partnership does not alter Ortivity's operating model, which continues to be under a physician-led partnership.

The partnership between Ortivity and Unigestion is seen as a validation of Ortivity's physician-led model. Unigestion, a mid-market private equity specialist, is investing around 200 million euros in Ortivity and taking a minority stake.

The transaction between Ortivity and Unigestion is subject to customary regulatory approvals. The partnership does not significantly alter the ownership distribution among doctors and capital providers.

This investment marks a significant step forward for Ortivity, reinforcing its commitment to delivering high-quality orthopedic care and setting new standards in patient-centered services.

Munich-based firm Ortivity raises substantial funding for their physician-focused business model